alpha-tocopherol quinol has been researched along with Kidney Failure, Chronic in 1 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begum, R; Belury, MA; Burgess, JR; Peck, LW | 1 |
1 trial(s) available for alpha-tocopherol quinol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
Topics: Adult; Aged; alpha-Tocopherol; Arachidonate 5-Lipoxygenase; Dietary Fats, Unsaturated; Double-Blind Method; Erythrocytes; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Fish Oils; gamma-Tocopherol; Humans; Kidney Failure, Chronic; Leukotriene B4; Male; Middle Aged; Neutrophils; Prospective Studies; Pruritus; Renal Dialysis; Safflower Oil; Surveys and Questionnaires | 2004 |